We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+3.49%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
AUM
$6.26B
AUM Growth
+$473M
Cap. Flow
+$398M
Cap. Flow %
6.35%
Top 10 Hldgs %
23.68%
Holding
293
New
38
Increased
125
Reduced
71
Closed
38

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$48.5M
2
MRK icon
Merck
MRK
+$37.3M
3
AMGN icon
Amgen
AMGN
+$35M
4
EW icon
Edwards Lifesciences
EW
+$29.3M
5
BAH icon
Booz Allen Hamilton
BAH
+$26.3M

Sector Composition

Rank Sector Weight
1 Financials 23.24%
2 Technology 21.39%
3 Healthcare 21.13%
4 Communication Services 9.82%
5 Industrials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$293M 4.67%
1,309,500
GOOG icon
2
Alphabet (Google) Class C
GOOG
$3.9T
$222M 3.55%
5,755,480
+455,580
+9% +$17.7M
AAPL icon
3
Apple
AAPL
$4.89T
$143M 2.29%
4,949,572
-283,700
-5% -$8.04M
CB icon
4
Chubb
CB
$140B
$130M 2.07%
982,760
+102,329
+12% +$13M
MSFT icon
5
Microsoft
MSFT
$2.84T
$127M 2.04%
2,051,677
+253,484
+14% +$15.2M
META icon
6
Meta Platforms (Facebook)
META
$1.51T
$124M 1.98%
1,079,232
+45,053
+4% +$5.53M
ACGL icon
7
Arch Capital
ACGL
$36.1B
$115M 1.83%
3,993,798
+475,647
+14% +$12.9M
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.07T
$114M 1.82%
700,449
+75,332
+12% +$11.6M
ELV icon
9
Elevance Health
ELV
$81.9B
$110M 1.76%
766,956
+258,417
+51% +$34.6M
MKL icon
10
Markel Group
MKL
$25B
$104M 1.66%
115,187
+24,536
+27% +$21.9M
C icon
11
Citigroup
C
$222B
$102M 1.63%
1,713,243
+159,138
+10% +$8.59M
GOOGL icon
12
Alphabet (Google) Class A
GOOGL
$3.91T
$101M 1.61%
2,549,000
-8,760
-0.3% -$350K
SU icon
13
Suncor Energy
SU
$77.7B
$99.9M 1.6%
2,576,151
+279,193
+12% +$8.56M
PFE icon
14
Pfizer
PFE
$140B
$96.9M 1.55%
3,144,689
+245,624
+8% +$7.5M
VR
15
DELISTED
Validus Hold Ltd
VR
$89.3M 1.43%
1,622,981
+136,424
+9% +$7.21M
INTC icon
16
Intel
INTC
$464B
$87.6M 1.4%
2,415,955
+285,604
+13% +$10.2M
JPM icon
17
JPMorgan Chase
JPM
$939B
$82M 1.31%
950,539
-239,168
-20% -$18.2M
PEP icon
18
PepsiCo
PEP
$186B
$73.3M 1.17%
700,272
+81,995
+13% +$8.59M
AMZN icon
19
Amazon
AMZN
$2.5T
$72.1M 1.15%
1,922,200
-27,800
-1% -$1.09M
V icon
20
Visa
V
$677B
$70.2M 1.12%
899,923
-69,114
-7% -$5.56M
CNQ icon
21
Canadian Natural Resources
CNQ
$96.9B
$65.8M 1.05%
3,520,839
+643,879
+22% +$10.2M
MRSH
22
Marsh
MRSH
$86.3B
$64M 1.02%
947,500
+232,500
+33% +$15.6M
UNP icon
23
Union Pacific
UNP
$182B
$60M 0.96%
579,126
+43,503
+8% +$4.28M
AME icon
24
Ametek
AME
$55.5B
$59.1M 0.94%
1,216,714
+614,823
+102% +$29.1M
DOX icon
25
Amdocs
DOX
$5.53B
$57.3M 0.91%
983,902
+20,009
+2% +$1.18M

Similar funds

Polar Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Polar Capital held 293 positions worth $6.26B, up 8.2% from $5.79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Polar Capital deployed $398M of net new capital in Q4 2016, opening 38 new positions and adding to 125 existing holdings. Its largest new stake was Aetna Inc: 279,500 shares worth $34.7M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $48.5M trimmed.

  • Polar Capital's largest Q4 2016 buy was Aetna Inc: 279,500 shares worth $34.7M.
  • Polar Capital added most to Alexion Pharmaceuticals in Q4 2016, an estimated $53.8M increase.
  • Polar Capital's biggest Q4 2016 reduction was Johnson & Johnson, cutting an estimated $48.5M.
  • Polar Capital fully exited Edwards Lifesciences in Q4 2016, selling an estimated $29.3M.
  • Polar Capital's ten largest holdings make up 24% of its $6.26B portfolio in Q4 2016.
  • Polar Capital opened 38 new positions and closed 38 in Q4 2016.
  • Polar Capital's portfolio value rose 8.2% quarter-over-quarter to $6.26B.

Based on Polar Capital's 13F filing for Q4 2016, filed 14 Feb 2017.